ABBOTT LABORATORIES — Director's Dealing 2011

Feb 10, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-02-08

Reporting Person: Hance Robert B (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-08	Common shares without par value	M	53202	$45.4488	Acquired	168600	Direct
2011-02-08	Common shares without par value	S	25602	$45.46	Disposed	142998	Direct
2011-02-08	Common shares without par value	S	7000	$45.465	Disposed	135998	Direct
2011-02-08	Common shares without par value	S	700	$45.467	Disposed	135298	Direct
2011-02-08	Common shares without par value	S	1500	$45.469	Disposed	133798	Direct
2011-02-08	Common shares without par value	S	9400	$45.47	Disposed	124398	Direct
2011-02-08	Common shares without par value	S	1300	$45.475	Disposed	123098	Direct
2011-02-08	Common shares without par value	S	4800	$45.48	Disposed	118298	Direct
2011-02-08	Common shares without par value	S	200	$45.4825	Disposed	118098	Direct
2011-02-08	Common shares without par value	S	400	$45.485	Disposed	117698	Direct
2011-02-08	Common shares without par value	S	2300	$45.50	Disposed	115398	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-08	Option (right to buy)	$45.4488	M	53202	Disposed	2011-02-08	Common shares (53202)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	6366	Indirect
Common shares without par value	20000	Indirect
Common shares without par value	150	Indirect
Common shares without par value	150	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 8, 2011.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.